APPARATUS, METHOD, AND COMPUTER READABLE MEDIUM FOR DISPLAYING GENERAL LEDGER FUNDS IN A CHECKBOOK FORMAT
    82.
    发明申请
    APPARATUS, METHOD, AND COMPUTER READABLE MEDIUM FOR DISPLAYING GENERAL LEDGER FUNDS IN A CHECKBOOK FORMAT 审中-公开
    用于在CHECKBOOK FORMAT中显示一般LEDGER基金的装置,方法和计算机可读介质

    公开(公告)号:US20140279316A1

    公开(公告)日:2014-09-18

    申请号:US14354485

    申请日:2012-11-07

    CPC classification number: G06Q40/12 G06Q10/10 G06Q40/02

    Abstract: Apparatus, computer readable medium, and a method for interacting with a user on a computer for displaying grants, the method comprising displaying grants with an icon indicating a balance of the grant; and in response to a selection of one of the displayed grants comprising transactions by the user, displaying transactions of the selected grant in a row comprising a column for transactions that lower the balance, a column for transactions that raise the balance, and a column for the balance, and displaying an icon for the column for transactions that lowers the balance and an icon for the column for transactions that raises the balance. The method may comprise retrieving credits and debits and displaying in the column for transactions that lower the balance, credits and debits that lower the balance, and displaying in the column for transactions that raise the balance, credits and debits that raise the balance.

    Abstract translation: 一种装置,计算机可读介质以及用于与计算机上的用户进行交互以显示授权的方法,所述方法包括显示具有指示授权余额的图标的授权; 并且响应于所选择的显示的授权中的一个包括用户的交易,显示所选择的授权在一行中的交易,其包括用于降低余额的交易的列,用于增加余额的交易的列,以及用于 余额,并显示用于降低余额的交易的列的图标,以及用于增加余额的交易的列的图标。 该方法可以包括检索信用和借记,并在列中显示降低余额的交易的交易,降低余额的信用和借方,并在列中显示用于提高余额的交易的交易,贷方和借记。

    TREATMENT OF AMYLOID BETA AMYLOIDOSIS
    84.
    发明申请
    TREATMENT OF AMYLOID BETA AMYLOIDOSIS 审中-公开
    AMYLOID BETA AMYOLIDOSIS的治疗

    公开(公告)号:US20130310421A1

    公开(公告)日:2013-11-21

    申请号:US13826223

    申请日:2013-03-14

    Inventor: Domenico Pratico

    CPC classification number: A61K31/4709

    Abstract: Provided is a method for the treatment and/or prevention of an amyloid beta amyloidosis in a subject comprising the step of administering to the subject an effective amount of a 5-lipoxygenase-activating protein (FLAP) antagonist. In preferred embodiments, the FLAP antagonist is MK-591, or a pharmaceutically acceptable salt thereof. Also provided is a method for decreasing or preventing the deposition of beta amyloid in the brain of a subject comprising the step of administering to a subject an effective amount of a FLAP antagonist. In preferred embodiments, the FLAP antagonist is MK-591, or a pharmaceutically acceptable salt thereof.

    Abstract translation: 本发明提供了一种治疗和/或预防受试者中淀粉样蛋白β淀粉样变性的方法,包括向受试者施用有效量的5-脂肪氧合酶活化蛋白(FLAP)拮抗剂的步骤。 在优选的实施方案中,FLAP拮抗剂是MK-591或其药学上可接受的盐。 还提供了减少或预防患者脑中β淀粉样蛋白沉积的方法,包括向受试者施用有效量的FLAP拮抗剂的步骤。 在优选的实施方案中,FLAP拮抗剂是MK-591或其药学上可接受的盐。

    CHOCOLATE PRODUCTION METHOD AND APPARATUS

    公开(公告)号:US20130202752A1

    公开(公告)日:2013-08-08

    申请号:US13755033

    申请日:2013-01-31

    CPC classification number: A23G1/0006 A23G1/0046 A23G1/18 A23V2002/00

    Abstract: The present invention relates to a method and an apparatus for producing a chocolate product. The method includes delivering liquid chocolate having a viscosity through a pipe along a delivery path to a production station for producing the chocolate product. The liquid chocolate includes solid particles suspended within the liquid chocolate. The method changes the viscosity of the liquid chocolate by applying an electric field to the liquid chocolate in a direction along the delivery path of a strength and duration determined to aggregate the suspended solid particles into streamlined shapes extending along the direction of the delivery path.

    Styryl sulfone anticancer agents
    86.
    发明申请
    Styryl sulfone anticancer agents 审中-公开
    苯乙烯基砜抗癌剂

    公开(公告)号:US20030114538A1

    公开(公告)日:2003-06-19

    申请号:US10255218

    申请日:2002-09-26

    CPC classification number: C07C317/10 C07C317/14

    Abstract: Styryl sulfone compounds of the invention selectively inhibit proliferation of tumor cells, and induce apoptosis of tumor cells, while sparing normal cells. The compounds, which are useful in the treatment of cancer and other proliferative disorders, have (a) the formula II: 1 wherein n is zero or one; R1 is selected from the group consisting of hydrogen, chlorine, fluorine and bromine; R2 is selected from the group consisting of hydrogen, chlorine, fluorine, bromine, methyl and methoxy; and R3 is selected from the group consisting of hydrogen, chlorine and fluorine; provided, R2 may not be methyl or methoxy when R1 and R3 are both hydrogen and n is zero or one; and R1, R2 and R3 may not all be hydrogen when n is one; (b) the formula III: 2 wherein R1 is selected from the group consisting of hydrogen, chlorine, fluorine and bromine; or (c) or the formula IV: 3 wherein R1 is selected from the group consisting of fluorine and bromine, and R2 is selected from the group consisting of 2-chlorophenyl, 4-chlorophenyl, 4-fluorophenyl and 2-nitrophenyl.

    Abstract translation: 本发明的苯乙烯基砜化合物选择性抑制肿瘤细胞增殖,诱导肿瘤细胞凋亡,同时保护正常细胞。 可用于治疗癌症和其他增殖性疾病的化合物具有(a)式II:其中n为0或1; R1选自氢,氯,氟和溴; R2选自氢,氯,氟,溴,甲基和甲氧基; 并且R 3选自氢,氯和氟; 条件是,当R 1和R 3均为氢且n为0或1时,R 2可以不是甲基或甲氧基; 当n为1时,R 1,R 2和R 3可不全部为氢; (b)式III:其中R1选自氢,氯,氟和溴; 或(c)或式Ⅳ:其中R1选自氟和溴,R2选自2-氯苯基,4-氯苯基,4-氟苯基和2-硝基苯基。

Patent Agency Ranking